Skip to main content
. 2017 Apr 28;8(4):252–259. doi: 10.1136/flgastro-2017-100806

Figure 3.

Figure 3

Factors influencing use of liver biopsy in non-alcoholic fatty liver disease (NAFLD) assessment. ELF, Enhanced Liver Fibrosis; NASH, non-alcoholic steatohepatitis.